What Researchers Did
Doctors describe treating 2 patients who developed jaw bone damage linked to oral osteoporosis medication (bisphosphonates), using a blood-derived treatment called platelet-rich plasma, with hyperbaric oxygen added in one of the two cases.
What They Found
This is a report of 2 individual patient cases, not a controlled study, and both patients reached complete remission, defined as resolution of pain and complete closure of the exposed jaw bone. Platelet-rich plasma was used in both cases. Hyperbaric oxygen was used as an additional treatment in only one of the two cases. The abstract reports no statistics, sample size beyond these 2 patients, or hyperbaric oxygen pressure or session details.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a report of only 2 cases with no control group and no statistical testing, so the outcomes cannot be attributed with confidence to platelet-rich plasma, hyperbaric oxygen, or either treatment specifically, and the findings cannot be generalized beyond these 2 patients.